Globus Medical, Inc.GMEDNYSE
LOADING
|||

Analyst Sentiment

Analysts lean bullish — 79% recommend buying.

Consensus Rating
Buy
19 analysts·Moderate coverage
79%
Rating Distribution
Strong Buy
00%
Buy
1579%
Hold
421%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see modest upside — consensus target 14% higher.

Bear Case
$64.00
-29%
Consensus
$102.17
+14%
Bull Case
$115.00
+28%
Price Range19 analysts
Low
Consensus
High
$64.00
$115.00
Current Target
Current Price
$89.70
Upside to Target
$12.47

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Jan 30, 2026Needham
Globus Medical upgraded to Buy from Hold at Needham
Target:$112.00
+24.1%from $90.22
Jan 26, 2026Cowen & Co.
Globus Medical initiated with a Buy at TD Cowen
Target:$110.00
+18.3%from $92.98
Jan 9, 2026Canaccord Genuity
Globus Medical price target raised to $112 from $105 at Canaccord
Target:$112.00
+18.4%from $94.62
Jan 8, 2026Piper Sandler
Globus Medical price target raised to $115 from $90 at Piper Sandler
Target:$115.00
+27.0%from $90.54
Dec 17, 2025RBC Capital
Globus Medical price target raised to $100 from $92 at RBC Capital
Target:$100.00
+16.6%from $85.79
Dec 17, 2025Canaccord Genuity
Globus Medical price target raised to $105 from $90 at Canaccord
Target:$105.00
+22.4%from $85.79
Oct 28, 2025Stifel Nicolaus
Globus Medical resumed with a Hold at Stifel
Target:$64.00
+0.9%from $63.45
Oct 10, 2025RBC Capital
Globus Medical price target lowered to $88 from $95 at RBC Capital
Target:$88.00
+52.9%from $57.55
Dec 2, 2024Morgan Stanley
Morgan Stanley Upgrades Globus Medical (GMED) to Overweight
Target:$100.00
+16.9%from $85.52
Aug 28, 2024BTIG
Globus Medical price target raised to $77 from $75 at BTIG
Target:$77.00
+7.3%from $71.73
Aug 7, 2024Wells Fargo
Wells Fargo Upgrades Globus Medical (GMED) to Overweight
Target:$78.00
+10.6%from $70.53
Jul 15, 2024Morgan Stanley
Globus Medical price target raised to $71 from $67 at Morgan Stanley
Target:$71.00
-0.1%from $71.07
May 29, 2024BTIG
Globus Medical (GMED) PT Raised to $72 at BTIG
Target:$72.00
+9.9%from $65.49
May 20, 2024Piper Sandler
Globus Medical upgraded to Overweight from Neutral at Piper Sandler
Target:$80.00
+24.2%from $64.40
Mar 18, 2024BTIG
BTIG Upgrades Globus Medical (GMED) to Buy
Target:$60.00
+16.2%from $51.65
Sep 19, 2023Stifel Nicolaus
Globus Medical's Untapped Potential Beyond The NUVA Transaction; Analyst Turns Bullish
Target:$61.00
+15.0%from $53.04
Jan 6, 2023Morgan Stanley
Morgan Stanley Maintains Equal-Weight on Globus Medical, Raises Price Target to $78
Target:$78.00
+8.4%from $71.97
Dec 20, 2022Truist Financial
Truist Securities Maintains Buy on Globus Medical, Raises Price Target to $85
Target:$85.00
+19.1%from $71.36
Dec 12, 2022Wells Fargo
Wells Fargo Maintains Overweight on Globus Medical, Raises Price Target to $82
Target:$82.00
+12.1%from $73.13
Aug 5, 2022Piper Sandler
Piper Sandler Maintains Overweight on Globus Medical, Lowers Price Target to $75
Target:$75.00
+27.4%from $58.85
Jul 20, 2022Truist Financial
Truist Securities Maintains Buy on Globus Medical, Lowers Price Target to $71
Target:$71.00
+21.7%from $58.35
Jul 15, 2022Morgan Stanley
Morgan Stanley Maintains Equal-Weight on Globus Medical, Lowers Price Target to $62
Target:$62.00
+10.2%from $56.27
May 12, 2022Morgan Stanley
Morgan Stanley Maintains Equal-Weight on Globus Medical, Lowers Price Target to $68
Target:$68.00
+11.2%from $61.16
May 11, 2022RBC Capital
RBC Capital Maintains Outperform on Globus Medical, Lowers Price Target to $73
Target:$73.00
+21.7%from $59.97
May 11, 2022Needham
Needham Maintains Buy on Globus Medical, Lowers Price Target to $71
Target:$71.00
+16.0%from $61.22